# FDA recall D-0432-2023

> **The Harvard Drug Group** · Class II · drug recall initiated 2023-02-23.

## Product

Carbidopa and Levodopa Tablets, USP 25 mg/100 mg, 10x10 Unit Dose carton, Rx Only, Manufactured in Czech Republic by: Teva Czech Industries, s.r.o. Opava-Komarov, Czech Republic, Manufactured for: Teva Pharmaceuticals USA, Inc. Parsippany, NJ 07054, Packaged and Distributed by: Major Pharmaceuticals Indianapolis, IN 46268 USA. NDC 0904-7257-61, UPC 3 09047 25761 4

## Reason for recall

Packaging defect: observed packaging defect, blister packaging inadequately sealed.

## Distribution

Distributed Nationwide in the USA

## Key facts

- **Recall number:** D-0432-2023
- **Recalling firm:** The Harvard Drug Group
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2023-02-23
- **Report date:** 2023-03-08
- **Termination date:** 2024-04-30

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** La Vergne, TN, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0432-2023

## Citation

> AI Analytics. FDA recall D-0432-2023. Retrieved 2026-06-03 from https://api.ai-analytics.org/recall/D-0432-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*